Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease

Rosario Sanchez-Pernaute, Hyojin Lee, Michaela Patterson, Casper Reske-Nielsen, Takahito Yoshizaki, Kai C. Sonntag, Lorenz Studer, Ole Isacson

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The identity and functional potential of dopamine neurons derived in vitro from embryonic stem cells are critical for the development of a stem cell-based replacement therapy for Parkinson's disease. Using a parthenogenetic primate embryonic stem cell line, we have generated dopamine neurons that display persistent expression of midbrain regional and cell-specific transcription factors, which establish their proper identity and allow for their survival. We show here that transplantation of parthenogenetic dopamine neurons restores motor function in hemi-parkinsonian, 6-hydroxy-dopamine-lesioned rats. Exposure to Wnt5a and fibroblast growth factors (FGF) 20 and 2 at the final stage of in vitro differentiation enhanced the survival of dopamine neurons and, correspondingly, the extent of motor recovery of transplanted animals. Importantly for future development of clinical applications, dopamine neurons were post-mitotic at the time of transplantation and there was no tumour formation. These data provide proof for the concept that parthenogenetic stem cells are a suitable source of functional neurons for therapeutic applications.

Original languageEnglish
Pages (from-to)2127-2139
Number of pages13
JournalBrain
Volume131
Issue number8
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Dopaminergic Neurons
Parkinsonian Disorders
Embryonic Stem Cells
Primates
Stem Cells
Transplantation
Fibroblast Growth Factor 2
Mesencephalon
Parkinson Disease
Dopamine
Transcription Factors
Neurons
Cell Line
Therapeutics
Neoplasms
In Vitro Techniques

Keywords

  • Midbrain
  • Parkinson's disease
  • Parthenogenesis
  • Stem cells
  • Transplantation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Sanchez-Pernaute, R., Lee, H., Patterson, M., Reske-Nielsen, C., Yoshizaki, T., Sonntag, K. C., ... Isacson, O. (2008). Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain, 131(8), 2127-2139. https://doi.org/10.1093/brain/awn144

Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. / Sanchez-Pernaute, Rosario; Lee, Hyojin; Patterson, Michaela; Reske-Nielsen, Casper; Yoshizaki, Takahito; Sonntag, Kai C.; Studer, Lorenz; Isacson, Ole.

In: Brain, Vol. 131, No. 8, 2008, p. 2127-2139.

Research output: Contribution to journalArticle

Sanchez-Pernaute, R, Lee, H, Patterson, M, Reske-Nielsen, C, Yoshizaki, T, Sonntag, KC, Studer, L & Isacson, O 2008, 'Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease', Brain, vol. 131, no. 8, pp. 2127-2139. https://doi.org/10.1093/brain/awn144
Sanchez-Pernaute, Rosario ; Lee, Hyojin ; Patterson, Michaela ; Reske-Nielsen, Casper ; Yoshizaki, Takahito ; Sonntag, Kai C. ; Studer, Lorenz ; Isacson, Ole. / Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. In: Brain. 2008 ; Vol. 131, No. 8. pp. 2127-2139.
@article{d3478e010fc0467aae083e96f1487d87,
title = "Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease",
abstract = "The identity and functional potential of dopamine neurons derived in vitro from embryonic stem cells are critical for the development of a stem cell-based replacement therapy for Parkinson's disease. Using a parthenogenetic primate embryonic stem cell line, we have generated dopamine neurons that display persistent expression of midbrain regional and cell-specific transcription factors, which establish their proper identity and allow for their survival. We show here that transplantation of parthenogenetic dopamine neurons restores motor function in hemi-parkinsonian, 6-hydroxy-dopamine-lesioned rats. Exposure to Wnt5a and fibroblast growth factors (FGF) 20 and 2 at the final stage of in vitro differentiation enhanced the survival of dopamine neurons and, correspondingly, the extent of motor recovery of transplanted animals. Importantly for future development of clinical applications, dopamine neurons were post-mitotic at the time of transplantation and there was no tumour formation. These data provide proof for the concept that parthenogenetic stem cells are a suitable source of functional neurons for therapeutic applications.",
keywords = "Midbrain, Parkinson's disease, Parthenogenesis, Stem cells, Transplantation",
author = "Rosario Sanchez-Pernaute and Hyojin Lee and Michaela Patterson and Casper Reske-Nielsen and Takahito Yoshizaki and Sonntag, {Kai C.} and Lorenz Studer and Ole Isacson",
year = "2008",
doi = "10.1093/brain/awn144",
language = "English",
volume = "131",
pages = "2127--2139",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease

AU - Sanchez-Pernaute, Rosario

AU - Lee, Hyojin

AU - Patterson, Michaela

AU - Reske-Nielsen, Casper

AU - Yoshizaki, Takahito

AU - Sonntag, Kai C.

AU - Studer, Lorenz

AU - Isacson, Ole

PY - 2008

Y1 - 2008

N2 - The identity and functional potential of dopamine neurons derived in vitro from embryonic stem cells are critical for the development of a stem cell-based replacement therapy for Parkinson's disease. Using a parthenogenetic primate embryonic stem cell line, we have generated dopamine neurons that display persistent expression of midbrain regional and cell-specific transcription factors, which establish their proper identity and allow for their survival. We show here that transplantation of parthenogenetic dopamine neurons restores motor function in hemi-parkinsonian, 6-hydroxy-dopamine-lesioned rats. Exposure to Wnt5a and fibroblast growth factors (FGF) 20 and 2 at the final stage of in vitro differentiation enhanced the survival of dopamine neurons and, correspondingly, the extent of motor recovery of transplanted animals. Importantly for future development of clinical applications, dopamine neurons were post-mitotic at the time of transplantation and there was no tumour formation. These data provide proof for the concept that parthenogenetic stem cells are a suitable source of functional neurons for therapeutic applications.

AB - The identity and functional potential of dopamine neurons derived in vitro from embryonic stem cells are critical for the development of a stem cell-based replacement therapy for Parkinson's disease. Using a parthenogenetic primate embryonic stem cell line, we have generated dopamine neurons that display persistent expression of midbrain regional and cell-specific transcription factors, which establish their proper identity and allow for their survival. We show here that transplantation of parthenogenetic dopamine neurons restores motor function in hemi-parkinsonian, 6-hydroxy-dopamine-lesioned rats. Exposure to Wnt5a and fibroblast growth factors (FGF) 20 and 2 at the final stage of in vitro differentiation enhanced the survival of dopamine neurons and, correspondingly, the extent of motor recovery of transplanted animals. Importantly for future development of clinical applications, dopamine neurons were post-mitotic at the time of transplantation and there was no tumour formation. These data provide proof for the concept that parthenogenetic stem cells are a suitable source of functional neurons for therapeutic applications.

KW - Midbrain

KW - Parkinson's disease

KW - Parthenogenesis

KW - Stem cells

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=49449109011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49449109011&partnerID=8YFLogxK

U2 - 10.1093/brain/awn144

DO - 10.1093/brain/awn144

M3 - Article

C2 - 18669499

AN - SCOPUS:49449109011

VL - 131

SP - 2127

EP - 2139

JO - Brain

JF - Brain

SN - 0006-8950

IS - 8

ER -